Axon Neuroscience SE
Records under this name other than the patents Axon Neuroscience SE holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 4 of 4 · Back to Axon Neuroscience SE
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,485,972 | Truncated tau proteins Lapsed on the fee record Ended Nov 8, 2024 · USPTO record | Lapsed on the fee record | Ended Nov 8, 2024 | USPTO record |
| US 8,288,608 | Transgenic animal expressing alzheimer's tau protein Term ended Term ended Jul 9, 2023 · USPTO record | Term ended | Term ended Jul 9, 2023 | USPTO record |
| US 9,161,520 | Transgenic animal expressing Alzheimer's tau protein Term ended Term ended Jul 9, 2023 · USPTO record | Term ended | Term ended Jul 9, 2023 | USPTO record |
| US 7,446,180 | Conformationally abnormal forms of tau proteins and specific antibodies thereto Term ended Term ended Aug 6, 2022 · USPTO record | Term ended | Term ended Aug 6, 2022 | USPTO record |